OHSU is recognized by DNV GL Healthcare as a Cardiac Center of Excellence.

Hospitals in the Portland metro area have seen an increase in respiratory cases due to wildfire smoke.

An OHSU study with Oregon State University finds that overweight but otherwise healthy people lose weight with a dietary supplement of lipoic acid.

Martin Schreiber, M.D., is interviewed about a landmark study showing positive outcomes for traumatic brain injury among patients treated with 2 grams of tranexamic acid.

OHSU is one of many health care employers across the nation that have opted out of the President’s payroll tax deferral.

John Kaufman M.D. authors new clinical practice guidelines on the use of inferior vena cava filters to treat venous thromboembolism.

An article features comment from Marcia Friedman, M.D., about symptoms, diagnoses and treatment of inflammatory disorders such as polymyalgia rheumatica and giant cell arteritis.

Juliette Preston, M.D., is quoted in a story about healthier ways to handle a headache.

New research from OHSU for the first time documents the presence of astrocytes in zebrafish, a milestone that will open new avenues of research into a glial cell critical for nearly every aspect of brain function and assembly.

South China Morning Post reports on the promise and peril of the gene-editing tool CRISPR, setting the scene at OHSU, which performed the first-ever use of CRISPR in a living human patient to address a blindness-causing gene mutation.